Evidence map›Paper›PMID 36009923›Full record

ArticleAntibiotics (Basel, Switzerland)2022

A Promising Antifungal and Antiamoebic Effect of Silver Nanorings, a Novel Type of AgNP.

Sara González-Fernández, Victor Lozano-Iturbe, Mª Fe Menéndez, Helena Ordiales, Iván Fernández-Vega, Jesús Merayo, Fernando Vazquez, Luis M Quirós, Carla Martín

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Silver and Gold Compounds as Antibiotics.Antibiotics (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sara González-FernándezDepartment of Functional Biology, University of Oviedo, 33006 Oviedo, Spain.ORCID 0000-0003-4487-3906
Victor Lozano-IturbeDepartment of Functional Biology, University of Oviedo, 33006 Oviedo, Spain.
Mª Fe MenéndezDepartment of Photonics, ITMA Materials Technology, 33490 Avilés, Spain.
Helena OrdialesDepartment of Functional Biology, University of Oviedo, 33006 Oviedo, Spain.
Iván Fernández-VegaInstituto Universitario Fernández-Vega, University of Oviedo, Av. Drs Fernández Vega 34, 33012 Oviedo, Spain.ORCID 0000-0002-3141-6493
Jesús MerayoInstituto Universitario Fernández-Vega, University of Oviedo, Av. Drs Fernández Vega 34, 33012 Oviedo, Spain.
Fernando VazquezDepartment of Functional Biology, University of Oviedo, 33006 Oviedo, Spain.
Luis M QuirósDepartment of Functional Biology, University of Oviedo, 33006 Oviedo, Spain.ORCID 0000-0003-3505-3762
Carla MartínDepartment of Functional Biology, University of Oviedo, 33006 Oviedo, Spain.ORCID 0000-0001-5353-5461
Universidad de Oviedo · ES

Funding

Gobierno del Principado de Asturias IDE/2019/000366
6 · The paper itself

Abstract

Silver nanoparticles (AgNPs) play an important role in the medical field due to their potent antimicrobial activity. This, together with the constant emergence of resistance to antimicrobial drugs, means AgNPs are often investigated as an alternative to solve this problem. In this article, we analyzed the antifungal and antiamoebic effects of a recently described type of AgNP, silver nanorings (AgNRs), and compared them with other types of AgNPs. Tests of the activity of AgNPs against various fungal and amoebic species were carried out. In all cases, AgNPs showed a high biocidal effect, although with fungi this depended on the species involved. Antifungal activity was detected by the conditioning of culture media or water but this effect was not dependent on the release of Ag ions. On the other hand, the proliferation of

Indexed as

antiamoebicsantifungalssilver nanoparticlessilver nanoringssilver nanospheressilver nanowires

Identifiers

PMID36009923
PMCPMC9405138
OpenAlexW4289704899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.